Search Results for: covid-19
Articles
Global Regulators Discuss Observational Studies of Real-World Data for COVID-19 Medicines
In a recent dedicated COVID-19 workshop, organized by the European Medicines Agency (EMA) under the umbrella of the International Coalition...Novavax Identifies COVID-19 Vaccine Candidate; Accelerates Initiation of First-in-Human Trial to Mid-May
Novavax, Inc. recently announced it has identified a coronavirus vaccine candidate, NVX-CoV2373, a stable, prefusion protein made using Novavax’ proprietary...COVID-19 Therapeutics: Summary of Recently Published Clinical Study using Hydroxychloroquine
Hydroxychloroquine sulphate (Plaquenil) an analog of chloroquine has an established track record for treating malaria and has demonstrated in vitro activity against the SARS-CoV and therefore …..
SGS Digicomply Launches AI System to Find Answers on COVID-19 Within Research Articles
SGS Digicomply recently announced the launch of a new version of its software dedicated exclusively to the research community and focused on finding….
N4 Pharma Provides Covid-19 Project & Operational Update
N4 Pharma Plc, the specialist pharmaceutical company developing Nuvec, a novel delivery system for cancer treatments and vaccines, recently announced...Fast New Tests for Covid-19 on the Way
At present, polymerise chain reaction (PCR) and antibody testing are the dominant ways that global healthcare systems are testing citizens...Saama Makes State-of-the-Art Clinical Analytics Platform Available to Integrate Data From All Organizations Investigating COVID-19 Treatments
Saama Technologies, Inc. recently announced it will contribute its AI-powered Life Science Analytics Cloud (LSAC) technology platform to establish the EndPandemic National Data Consortium…..
Altimmune & the University of Alabama Collaborate on Development of Single-Dose, Intranasal COVID-19 Vaccine
Altimmune, Inc. recently announced it is launching a collaboration with the University of Alabama at Birmingham (UAB) on the development of its single-dose…..
Covid-19 Outbreak in China Threatens Biopharma In-House Manufacturing
With several mega cap biopharma companies having their vital manufacturing steps in Chinese facilities, the novel coronavirus (Covid-19) outbreak is putting the complicated global biopharma industry’s supply….
Pfizer & BioNTech to Co-develop Potential COVID-19 Vaccine
Pfizer Inc. and BioNTech SE recently announced the companies have agreed to a letter of intent regarding the co-development and distribution (excluding China) of a….
